0001104659-21-151738.txt : 20211220 0001104659-21-151738.hdr.sgml : 20211220 20211220164349 ACCESSION NUMBER: 0001104659-21-151738 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211216 FILED AS OF DATE: 20211220 DATE AS OF CHANGE: 20211220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dugel Pravin CENTRAL INDEX KEY: 0001700917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 211505770 MAIL ADDRESS: STREET 1: C/O AERPIO PHARMACEUTICALS, INC. STREET 2: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PENN PLAZA STREET 2: SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: 5 PENN PLAZA STREET 2: SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 tm2135829-3_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-12-16 0 0001410939 IVERIC bio, Inc. ISEE 0001700917 Dugel Pravin C/O IVERIC BIO, INC. 5 PENN PLAZA, SUITE 2372 NEW YORK NY 10001 0 1 0 0 President Stock Option (Right to Buy) 14.83 2021-12-16 4 A 0 100000 0 A 2031-12-16 Common Stock 100000 100000 D Restricted Stock Units 2021-12-16 4 A 0 50000 0 A Common Stock 50000 50000 D Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares, in approximately equal monthly installments through the fourth anniversary of the grant date. Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026). /s/ Todd Anderman, as Attorney-in-Fact for Pravin Dugel 2021-12-20